Home
World Journal of Biology Pharmacy and Health Sciences
ISSN Approved | International, Peer reviewed, Referred, Open access Journal

Main navigation

  • Home
    • Journal Information
    • Abstracting and Indexing
    • Editorial Board Members
    • Reviewer Panel
    • Journal Policies
    • WJBPHS CrossMark Policy
    • Publication Ethics
    • Current Issue
    • Issue in Progress
    • Past Issues
    • Instructions for Authors
    • Article processing fee
    • Track Manuscript Status
    • Get Publication Certificate
    • Become a Reviewer panel member
    • Join as Editorial Board Member
  • Contact us
  • Downloads

ISSN Approved Journal | | IMPACT FACTOR 8.16 | | eISSN: 2582-5542 | |  Free Crossref DOI 

Fast Publication within 2 days | | Low Article Processing Charges | | Peer Reviewed and Referred Journal

Research and review articles are invited for publication in September 2026 (Volume 27, Issue 3) Submit Paper

Prevalence Of hemodilution and hemoconcentration in medically hospitalized patients across dichotomized outcome-related cohorts

Breadcrumb

  • Home
  • Prevalence Of hemodilution and hemoconcentration in medically hospitalized patients across dichotomized outcome-related cohorts

Ahmad Al Mbaidheen 1, *, Anas Darawsheh 2, Mohammed Bani Hani 1, Wala' Ali Issa Al Mzied 1 and Luma Ibraheem Mohammad Alryalat 1

1 Internal Medicine Specialist, Department of Internal Medicine, King Husein Medical Services, Jordanian Royal Medical Services, Amman, Jordan.
2 Rheumatologist, Department of Rheumatology, King Husein Medical Services, Jordanian Royal Medical Services, Amman, Jordan.
 

Research Article

World Journal of Biology Pharmacy and Health Sciences, 2025, 23(01), 150–158

Article DOI: 10.30574/wjbphs.2025.23.1.0628

DOI url: https://doi.org/10.30574/wjbphs.2025.23.1.0628

Received on 19 June 2025; revised on 05 July 2025; accepted on 08 July 2025

Aims: The goal of this research is to find out how frequently hospitalized individuals have hemodilution and hemoconcentration, as well as what implications these conditions have on their daily lives. It seeks to fill in a gap in what we know by offering us fresh information and research in a field that is vital for treatment. The findings might change how medical hospitals in Jordan care for patients, but they could also change how other nations with comparable patients and illness burdens care for them.
Methods: The purpose of this retrospective cohort research was to find out whether there was a connection between the number of times patients at King Hussein Medical Services and Royal Medical Services in Jordan experienced hemodilution and hemoconcentration and the outcomes of their clinical tests. One part of the study's research on electronic medical information was placing patients into two groups depending on their findings, how long they were in the hospital, and any difficulties they had. A p-value of less than 0.05 was regarded statistically significant, and the findings demonstrated that hemoconcentration and hemodilution were strongly linked. The study's confirmation methods, which included random checks and listwise exclusion, made sure that the data was accurate and that ethical criteria were followed. The study's purpose was to find out how beneficial these blood issues may be as measurements and what role they play in real life.
Results: The results were not significantly affected by gender, age, HLOS, or body mass index (BMI). Most of the people in the "Positive State or Poorer OI" and "Negative State or Better OI" categories were women. Most of the people in the "Negative State or Better OI" category were males. There was no statistically significant connection between BMI and either good or bad. But there was a clear connection between prolonged HLOS and lower outcomes. There is a connection between low levels of albumin, hemoglobin, and hemoglobin content and negative lab test results. In the grand scheme of things, these things don't really matter. The research showed that the hemodilution/hemoconcentration state (HHR) did not impact the findings for patients. Patients with an AACCI score of seven or above, which was the poorest group, were strongly linked to poorer outcomes. There was a substantial negative link between having a lower HALP number and having more terrible things occurring
Conclusion: The Systemic Immune-Inflammation Index (SII) was the greatest technique to find out how much inflammation was going on in the body. Age and gender, which are social determinants, did not affect the outcomes. HLOS, ALB, Hgb, Hct, AACCI, HALP, and SII were all signs that helped us figure out what would happen.

Hemodilution; Hemoconcentration; Medical Inpatients; Outcomes; Fluid Balance; Retrospective Study

https://wjbphs.com/sites/default/files/fulltext_pdf/WJBPHS-2025-0628.pdf

Preview Article PDF

Ahmad Al Mbaidheen, Anas Darawsheh, Mohammed Bani Hani, Wala' Ali Issa Al Mzied and Luma Ibraheem Mohammad Alryalat. Prevalence Of hemodilution and hemoconcentration in medically hospitalized patients across dichotomized outcome-related cohorts. World Journal of Biology Pharmacy and Health Sciences, 2025, 23(01), 150-158. Article DOI: https://doi.org/10.30574/wjbphs.2025.23.1.0628. 

Get Certificates

Get Publication Certificate

Download LoA

Check Corssref DOI details

Issue details

Issue Cover Page

Editorial Board

Table of content


Copyright © Author(s). All rights reserved. This article is published under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, sharing, adaptation, distribution, and reproduction in any medium or format, as long as appropriate credit is given to the original author(s) and source, a link to the license is provided, and any changes made are indicated.


Copyright © 2026 World Journal of Biology Pharmacy and Health Sciences (WJBPHS) - All rights reserved

Developed & Designed by VS Infosolution